Result: Risk Minimisation Materials for medicines starting with the letter S
Sarclisa
Sanofi Genzyme

Sarclisa HCP Brochure
This brochure contains important information for HCPs & blood banks concerning the appropriate measures to manage isatuximab interference and avoid possible resulting adverse clinical consequences and to inform that isatuximab may interfere with routine blood compatibility tests with potential false positive reactions in the indirect antiglobulin test (indirect Coombs test). For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
For Healthcare Professionals

Sarclisa Patient Alert Card
This patient alert card contains important safety information that you need to be aware of before, during, and after treatment with SARCLISA. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
Sialanar
Proveca Limited

Checklist for Healthcare Professionals
These educational materials focus on the provision of advice for the recognition of anticholinergic effects that can be associated with glycopyrronium bromide containing products and how best to manage specific events.
For Healthcare Professionals

Healthcare Professional Checklist Labels
This is a sheet of checklist labels to help record anticholinergic effects in a patient’s notes.
For Healthcare Professionals

Reminder Card for Caregivers
These educational materials focus on the provision of advice for the recognition of anticholinergic effects that can be associated with glycopyrronium bromide containing products and how best to manage specific events.
Siklos
Masters Pharmaceuticals Ltd

Patient's Guide to Siklos
This Siklos Patient Guide contains important information about your treatment, or your child's treatment including advice on preparation and administration of your medicine, disease symptoms, and side effects.

Physicians Guide to Siklos
This Physician Guide for Siklos contains important recommendations for patient monitoring, dosage adjustments, and the management of serious adverse effects.
For Healthcare Professionals
Simponi
Merck Sharp & Dohme (UK) Limited

Patient Reminder Card
This risk minimisation material is a condition of the marketing authorisation. This card should be provided to patients receiving treatment with golimumab. It gives important safety information for the patient and allow important details of their treatment to be recorded
Sixmo
Accord-UK Ltd

Sixmo 74.2 mg implant Training
Training materials for Healthcare professionals
For Healthcare Professionals
Skilarence
Almirall Limited

Healthcare Professional Guideline - Important safety information for Skilarence (dimethyl fumarate)
This guideline is intended to inform HCPs about the risk of serious infections, mainly opportunistic infections such as progressive multifocal leukoencephalopathy (PML), associated with the use of Skilarence and to provide guidance on how to minimise and manage this risk through appropriate monitoring of lymphocyte and leukocyte count abnormalities.
For Healthcare Professionals
Sodium glycerophosphate
Martindale Pharma, an Ethypharm Group Company

How to take Oxybate 500mg/ml oral solution (sodium oxybate)
How to take Oxybate 500mg/ml oral solution (sodium oxybate)

Important safety information for patients
Important safety information for patients

Sodium Oxybate 500mg/ml oral solution (sodium oxybate) frequently asked questions information sheet
Be sure to speak with your healthcare professional about any other questions you may have, and review the package leaflet included with your medicine bottle.

Sodium Oxybate 500mg/ml oral solution (sodium oxybate) treatment initiation and follow-up visit form
This treatment initiation form is essential to ensure the safe and effective use of Sodium Oxybate 500 mg/ml oral solution and the appropriate management of the important risks. Please complete all sections of this form, sign and date and r etain in your patient’s medical records. Please also review the summary of product characteristics for complete information about this product.
For Healthcare Professionals
Sodium oxybate
Aristo Pharma Limited

How to take Sodium oxybate 500 mg/ml oral solution Brochure
Important risk minimisation information for Patients: How to take Sodium oxybate 500 mg/ml oral solution Brochure

Sodium Oxybate 500 mg/ml Oral Solution Frequently Asked Questions (FAQ) Information Sheet
Important risk minimisation information for Patients: Sodium oxybate 500 mg/ml oral solution Frequently Asked Questions (FAQ) Information Sheet
For Healthcare Professionals

Sodium Oxybate 500 mg/ml oral solution Patient Alert Card
Important safety information for patients, physicians and pharmacists.

Sodium oxybate 500 mg/ml oral solution Treatment Initiation and Follow-Up Visit Form
This treatment initiation form is essential to ensure the safe and effective use of Sodium oxybate 500 mg/ml oral solution and the appropriate management of the important risks.
For Healthcare Professionals
Sodium valproate
Wockhardt UK Ltd

Valproate - Annual Risk Acknowledgement Form
Patient Risk Acknowledgement Form


Valproate - Patient Guide
Guide on use of of valproate during pregnancy

Valproate - Patient Reminder Card
Patient Reminder Card


Sofiperla
Accord-UK Ltd

Combined hormonal contraceptives: Checklist for Prescribers
Combined hormonal contraceptives: Checklist for Prescribers
For Healthcare Professionals

Combined hormonal contraceptives: Important information for women
Combined hormonal contraceptives: Important information for women

Combined hormonal contraceptives: Important information for women about the risk of blood clots
Combined hormonal contraceptives: Important information for women about the risk of blood clots
Soliris
Alexion Pharma UK Ltd

Soliris Patient Safety Card
Important Safety Information for Patients Receiving Soliris® Show this card to any doctor involved in your care.

Soliris Patient/Parent Information
This guide is for adult patients and parents/legal guardians of a child who has been prescribed eculizumab. The guide provides you with important safety information that you must be aware of.

Soliris Physician's Guide
The aim of this brochure is to educate and/or remind healthcare professionals about the selected prevention measures, detection, careful monitoring and/or proper management of selected safety concerns associated with eculizumab.
For Healthcare Professionals
Stamaril
Sanofi Pasteur

Stamaril - Checklist to complete prior to Administration
For hard copies please contact our medical information department at 0800 035 2525 or email [email protected]
For Healthcare Professionals
Strensiq
Alexion Pharma UK Ltd

Strensiq Injection Guide for Parents/Caregivers
This Injection Guide is for the parents and caregivers of infant patients with paediatric-onset hypophosphatasia who would benefit from long-term enzyme replacement therapy and have been prescribed Strensiq®. The guide gives detailed instructions, with clear diagrams, on how to choose the injection site and how to carry out and record the injection of your infant or child. This guide is designed as a support document to the training given by your healthcare professional. Please contact your healthcare professional if you have any questions.

Strensiq Self-Injection Guide
This Self-Injection Guide is for patients with paediatric- onset hypophosphatasia who would benefit from long-term enzyme replacement therapy and have been prescribed Strensiq®. The guide gives detailed instructions, with clear diagrams, on how to choose your injection site and how to carry out and record your injection. This guide is designed as a support document to the training given by your healthcare professional. Please contact your healthcare professional if you have any questions.
Stribild
Gilead Sciences Ltd

Stribild HIV Paediatric Educational Brochure
Brochure providing important advice on the management of potential renal and bone effects of Stribild in HIV-1 infected adolescents aged 12 years and older
For Healthcare Professionals
Strontium ranelate
Aristo Pharma Limited

Stronium ranelate Aristo Patient Alert Card
Contains important safety information including possible side effects that patients need to be aware of before and during treatment with Strontium ranelate.
For Healthcare Professionals

Stronium ranelate Aristo Prescriber Guide and Checklist
Important information on minimising cardiovascular risks, venous thromboembolism and skin reactions with strontium ranelate.
For Healthcare Professionals
Suliqua
SANOFI

Suliqua- HCP Guide - Important information on dosing
For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
For Healthcare Professionals

Suliqua- Patient Guide - Important information on dosing
For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
Syonell
Lupin Healthcare (UK) Ltd

Valproate Annual Risk Acknowledgment Form
Valproate Annual Risk Acknowledgment Form

Valproate- Healthcare professionals (HCPs) Educational material Pregnancy prevention programme
Educational material for healthcare professionals (HCPs) about the Pregnancy Prevention Programme
For Healthcare Professionals

Valproate- Patient Card-Contraception and Pregnancy Prevention
Educational material for girls and women of childbearing potential about the Pregnancy Prevention Programme

Valproate- Patient Guide-Educational material- Pregnancy prevention programme
Educational material for girls and women of childbearing potential about the Pregnancy Prevention Programme

Valproate- Poster- Dispensary- Pregnancy Prevention Programme
For pharmacy use only. Dispensary information about the Pregnancy Prevention Programme
For Healthcare Professionals

Valproate- White Box Warning Labels
Valproate- White Box Warning Labels